Immunological studies of haemophilic patients with inhibitors treated with Factor VIII concentrates in a protocol to induce immunotolerance.
作者信息
Aznar J A, Jorquera J I, Carbonell F, Sánchez-Cuenca J M, Trenor A, De Andrés Medina R, Carmona E, González-Molina A
出版信息
Thromb Haemost. 1984 Oct 31;52(2):212-3.
PMID:6441305
Abstract
摘要
相似文献
1
2
Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors.可能影响伴有凝血因子 VIII 抑制剂的血友病患者免疫耐受治疗结果的变量。
Thromb Haemost. 1994 Nov;72(5):784-5.
3
Induction of immunotolerance in hemophilia for high titre inhibitor eradication: a long-term follow-up.血友病免疫耐受诱导用于消除高滴度抑制物：长期随访
Thromb Haemost. 1989 Nov 24;62(3):835-9.
4
Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective.血友病因子VIII治疗。免疫耐受。临床视角。
Haematologica. 2000 Oct;85(10 Suppl):113-6.
5
Inhibitors of factor VIII: detection and treatment.凝血因子VIII抑制剂：检测与治疗
Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:21-5.
6
7
Induction of immune tolerance with factor VIII concentrate in patients with hemophilia A and inhibitors.用凝血因子VIII浓缩物诱导甲型血友病伴抑制物患者的免疫耐受。
Prog Clin Biol Res. 1990;324:59-68.
8
Hemophilia.血友病
N Engl J Med. 2001 Oct 4;345(14):1066; author reply 1067.
9
10
Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.尽管该治疗预后不佳，但对于一名患有先天性血友病且凝血因子 VIII 抑制物效价高的患者，使用高剂量凝血因子 VIII 和静脉注射免疫球蛋白成功诱导了免疫耐受。
Med Sci Monit. 2009 Jun;15(6):CS105-11.
Zotero 插件